GUY1 confers complete female lethality and is a strong candidate for a male-determining factor in Anopheles stephensi
Abstract
Despite their importance in sexual differentiation and reproduction, Y chromosome genes are rarely described because they reside in repeat-rich regions that are difficult to study. Here, we show that Guy1, a unique Y chromosome gene of a major urban malaria mosquito Anopheles stephensi, confers 100% female lethality when placed on the autosomes. We show that the small GUY1 protein (56 amino acids in length) causes female lethality and that males carrying the transgene are reproductively more competitive than their non-transgenic siblings under laboratory conditions. The GUY1 protein is a primary signal from the Y chromosome that affects embryonic development in a sex-specific manner. Our results have demonstrated, for the first time in mosquitoes, the feasibility of stable transgenic manipulation of sex ratios using an endogenous gene from the male-determining chromosome. These results provide insights into the elusive M factor and suggest exciting opportunities to reduce mosquito populations and disease transmission.
https://doi.org/10.7554/eLife.19281.001eLife digest
Much like humans, Anopheles mosquitoes have a pair of sex chromosomes that determine whether they are male or female: females have two X chromosomes, while males have an X and a Y. Genetic evidence has indicated that there is a dominant male-determining factor on the Y chromosome that acts as a master switch to cause mosquitoes to develop into males. Mosquitoes that lack a Y chromosome, and hence the male-determining factor, therefore develop into the default female sex.
Because only female mosquitoes feed on blood and transmit disease-causing microbes – including those that cause malaria – there is strong interest in identifying the male-determining factor. Introducing this gene into females could allow mosquito sex ratios to be manipulated towards the harmless non-biting males.
In 2013, a study of male Anopheles stephensi mosquitoes identified a gene called Guy1 that is only found on the Y chromosome. Criscione et al. – who were involved in the 2013 study – now show that female A. stephensi mosquitoes die when the Guy1 gene is placed on their non-sex chromosomes.
Further investigation confirmed that the protein produced from the Guy1 gene kills the females. This protein is an initiating signal that affects embryonic development in a sex-specific manner, making it a strong candidate to be the male determining factor in A. stephensi. This is consistent with previous reports in which the master switches of sex determination could be manipulated to kill specific sexes in fruit flies and nematode worms.
Criscione et al. also found that males that carry the inserted Guy1 gene on their non-sex chromosomes – and so could potentially pass it on to both male and female offspring – are reproductively more competitive than their non-modified siblings under laboratory conditions. As the resulting female offspring would not survive, it is thus feasible, in principle, to genetically manipulate the sex ratio of the mosquitoes.
A future challenge will be to identify how the protein encoded by the Guy1 gene acts to kill female mosquitoes. This knowledge will help to investigate the feasibility of using genetically modified mosquitoes to reduce Anopheles populations in order to control malaria.
https://doi.org/10.7554/eLife.19281.002Introduction
Insects employ diverse sex-determination mechanisms at the chromosomal level including XX/XY, ZW/ZZ, XX/XO, and diploid/haploid chromosomal systems (Bopp et al., 2014; Bachtrog et al., 2014; Biedler and Tu, 2016). Similarly, the primary molecular signals that determine sex are highly divergent in insects. In honeybees which use the diploid/haploid system, heterozygosity of the complementary sex determiner (csd) gene is the primary signal that initiates female development ( Hasselmann et al., 2008). In silkworms a piRNA gene on the W chromosome triggers female development (Kiuchi et al., 2014). In the fruit fly Drosophila melanogaster, which has XX/XY sex chromosomes, the collective dose of X-linked signal elements (XSE) functions as the signal that specifies sex in the early embryo (Erickson and Quintero, 2007). However, a dominant male-determining factor (M) on the Y chromosome initiates male development in many other insects that contain XX/XY sex chromosomes (Sanchez, 2008; Biedler and Tu, 2016). Instead of a well differentiated and heteromorphic Y chromosome, mosquitoes of the Culicinae subfamily, which includes the genus Aedes, contain a homomorphic sex-determining chromosome that harbors an M factor in the male-determining locus (M-locus). A novel RNA-binding protein named Nix was recently shown to be an M factor in Aedes aegypti (Hall et al., 2015).
Despite rapid changes in the primary signals or master switches, two key transcription factors at the bottom of the sex-determination pathway, doublesex (dsx) and fruitless (fru), are highly conserved in insects. Sex-specific splicing of dsx and fru pre-mRNAs leads to the production of sex-specific DSX and FRU protein isoforms, which program sexual differentiation (Bopp et al., 2014). The alternative splicing of dsx and fru pre-mRNAs is often controlled by a protein complex that includes a fast-evolving transformer (TRA) and a conserved transformer 2 (TRA2), where TRA is the sex-specific protein in this TRA/TRA2 complex. Indeed, TRA often functions as an intermediate that transduces the selected sexual fate from the primary signal to the DSX and FRU effector molecules (Bopp et al., 2014). For example, in the medfly Ceratitis capitata, which has XX/XY sex chromosomes, a functional TRA is produced in the zygotic XX embryo as a result of splicing by a maternally deposited TRA/TRA2 complex, leading to female-specific dsx and fru splicing and thus the female sex, which is then maintained by the self-sustaining loop of tra splicing and function. In males, a yet-to-be-discovered M factor interrupts this loop of tra splicing, leading to the male sex (Pane et al., 2002). Sex-specific splicing of dsx and fru has been described in both Aedes and Anopheles mosquitoes, suggesting the presence of a TRA-like activity (Scali et al., 2005; Salvemini et al., 2011, 2013). However, a tra gene or its functional homolog has not yet been found in any mosquitoes.
Anopheles mosquitoes contain well-differentiated X and Y chromosomes and genetic evidence suggests that a dominant M factor on the Y chromosome controls male development in Anopheles mosquitoes (Baker and Sakai, 1979). The Anopheles Y chromosome also regulates mating behavior (Fraccaro et al., 1977). There is tremendous interest in deciphering Y gene function in non-model insects, including Anopheles mosquitoes, to shed light on the mechanism and evolution of sexual differentiation. There has also been strong interest in Y chromosome genes in Anopheles mosquitoes for translational motivations. Only female mosquitoes transmit disease pathogens because only females feed on blood. Thus, it is ideal, if not required, to release only males when considering genetic approaches for reducing mosquito populations or for replacing competent vector populations with populations that are refractory to disease transmission (e.g., [Collins, 1994; Benedict and Robinson, 2003; Windbichler et al., 2008; Fu et al., 2010; Black et al., 2011; Harris et al., 2012]). A better understanding of the Y chromosome function in sex-determination and male reproduction may provide novel targets for interference and lead to several practical applications. For example, transgenic lines may be obtained that produce male-only mosquitoes, resulting in more cost-effective mass production and sex separation methods than current approaches (e.g., [Papathanos et al., 2009]). Furthermore, releasing such transgenic males is theoretically much more efficient than classic sterile insect techniques in achieving population reduction and disease control because of the added benefit of male-bias in subsequent generations (Thomas et al., 2000; Schliekelman et al., 2005).
Despite strong interest and the availability of genomic resources (e.g., [Holt et al., 2002]), earlier systematic efforts failed to identify Y genes in Anopheles mosquitoes (Krzywinski et al., 2006). Several Y genes were recently discovered in An. stephensi and An. gambiae (Criscione et al., 2013; Hall et al., 2013) by sequencing males and females separately. None of these genes is homologous to the Nix gene in Ae. aegypti (Hall et al., 2015) or encodes a predicted RNA-binding protein or splicing factor. However, among the An. gambiae Y chromosome genes, gYG2 (An. gambiae Y Gene 2) is the most likely candidate for the M factor because it showed early embryonic expression (Hall et al., 2013) and it is the only Y gene that is shared among all species within the An. gambiae species complex (Hall et al., 2016). In a recent report, gYG2 (renamed YOB by the authors) was shown to confer female-specific lethality in a transient embryonic assay and shift doublesex (dsx) splicing towards the male isoform in an An. gambiae cell line, suggesting that gYG2/YOB functions as an M factor in An. gambiae (Krzywinska et al., 2016). Among the four Y genes identified in An. stephensi, Guy1 is the best candidate for the M factor because it is transcribed the earliest among all Y genes, at the very onset of embryonic development (Criscione et al., 2013).
Results
Transient embryonic injection of Guy1 caused male bias
Guy1 transcription is transient and its transcript tapers off approximately 8–12 hr after egg deposition (Criscione et al., 2013). We designed a plasmid, nGuy1 (Figure 1A), which contains the entire Guy1 gene with its native promoter that was shown to function in the early embryo (Criscione et al., 2013), to first test the function of Guy1 in An. stephensi by a transient embryonic assay. A plasmid that contains an enhanced green fluorescent protein (EGFP) marker controlled by D. melanogaster actin 5C promoter was co-injected to select for effective embryonic injections as indicated by the EGFP signal in the larvae. The adults that developed from EGFP positive larvae showed 25:1 and 19:2 male to female ratio (Table 1). When the same experiments were performed using Guy1m (Figure 1B), a plasmid that is identical to nGuy1 except for a point mutation that changed the start codon ATG to AAG, the male-bias phenotype was no longer observed (Table 1), suggesting that the GUY1 protein is the cause of the phenotype.
Transgenic lines that ectopically express the native Guy1 gene produced only male transformants over 15 generations
Both nGuy1and Guy1m are piggyBac donor plasmids that contain the DsRed transformation marker (Figure 1). We were able to obtain transgenic lines using these donor plasmids together with a piggyBac helper plasmid to achieve germ line transposition. Two independent nGuy1 transgenic lines and one Guy1m line were obtained. Only a single transgene was inserted in each line, as indicated by digital droplet PCR (not shown), a method that quantifies gene copy number (Hindson et al., 2011). Inverse PCR and sequencing revealed independent insertion of the transgene in the two nGuy1 lines as the two nGuy1 insertion sites mapped to two different scaffolds (Supplementary file 3). Not a single transgenic female older than the third instar has been detected since we established the nGuy1 lines, while 2661 transgenic positive males were identified over 15 generations (Figure 1 and Supplementary file 1). Similar to what was observed during the transient assay, the Guy1m line showed no male-bias (Figure 1B and Supplementary file 1). Both nGuy1 and Guy1m transgenes are expressed in the early embryos in their respective lines (Figure 2A and B). Table 2 shows the numbers of transgene positive and negative males and females of the seventh generation (G7). The lack of sex-bias in the non-transgenic progeny in all three lines indicates autosomal insertion of the transgenes.
Further evidence suggests that the 56 amino acid GUY1 protein is responsible for the lack of female transformants
Two additional transgenic lines were obtained using bGuy1C (Figure 1C), which contains the 168 bp Guy1 open reading frame (ORF) plus a C-terminal Strep II tag (Lichty et al., 2005). The expression of bGuy1C is controlled by an An. stephensi early zygotic promoter derived from the bZip1 gene (Genbank JQ266223). The 5’UTR is provided from bZip1 and the 3’ UTR from SV40. Thus, the only Guy1 sequence in bGuy1C is the ORF. Nine additional transgenic lines were obtained using bGuy1N (Figure 1D), a plasmid similar to bGuy1C except that the Strep II tag is at the N-terminus and the 119bp Guy1 3’ UTR was used instead of the SV40 3’ UTR. These 11 lines were produced from different G0 pools and, thus, are likely all independent. The bGuy1C lines produced 1156 transgenic males and 0 transgenic females and all nine bGuy1N lines produced 2703 transgenic males and 0 transgenic females in G2-4 (Figure 1 and Supplementary file 2). The early zygotic transcription of the Guy1 transgene is shown in Figure 2C and D. Transgenic lines that contain a functional Guy1 gene (nGuy1, bGuy1C, and bGuy1N) produced 6520 transgenic males and zero transgenic females. These results further indicate that the GUY1 protein is the cause of the lack of females because the common feature of these lines is the Guy1 ORF while the promoters, 5’ and 3’ untranslated regions differ.
Female-killing, not sex conversion, is the cause of the male-only phenotype
The observation that all transgenic mosquitoes were males could result from either lethality or sex conversion of the XX individuals. We took advantage of an existing transgenic line that has a cyan fluorescent protein (CFP) marker cassette inserted on the X chromosome (XCFP) (Amenya et al., 2010) to monitor the genotype. The presence of the nGuy1 transgene on an autosome (AGUY1) is monitored by the DsRed marker. Figure 3A shows the schematic of the crosses performed to produce progeny whose genotype can be monitored by CFP and DsRed expression (Figure 3B). First, AGUY1aXY males were mated with aaXCFPXCFP females to obtain the AGUY1aXCFPY F1 progeny. These AGUY1aXCFPY males were subsequently crossed with wild type females (aaXX) to obtain progeny with four possible genotypes that can be differentiated based on CFP and DsRed expression: (1) AGUY1aXY, DsRed positive and CFP negative; (2) AGUY1aXCFPX, DsRed positive and CFP positive; (3) aaXCFPX, DsRed negative and CFP positive; and (4) aaXY, DsRed negative and CFP negative. As shown in Figure 3C and Figure 3—source data 1, there is a complete lack of DsRed/CFP double positives when the F2 progeny were screened at 4th instar larvae (L4), indicating the lack of AGUY1aXCFPX larvae. All DsRed positives were confirmed to be males by the presence of a pair of testes. Sexing method was confirmed by allowing the larvae to develop into adults. We then repeated these experiments by screening the L1 instars to determine the timing of the death of AGUY1aXCFPX individuals. In four replicates, only 2–4% of the L1 larvae showed the AGUY1aXCFPX genotype and they all died within 8 hr of hatching. Thus, we have seen complete lethality of transgenic XX individuals prior to, or soon after, egg hatching.
-
Figure 3—source data 1
- https://doi.org/10.7554/eLife.19281.008
Reproductive competitiveness of the nGuy1 males under laboratory conditions
Figure 4 and Figure 4—source data 1 show the results of the experiments to assess the reproductive competitiveness of the nGuy1 males under laboratory conditions. To mitigate the effect of different genetic backgrounds, transgenic males and their non-transgenic sibling males were subjected to competition for wild type virgin females. Two days after emergence, 20 transgenic males and 20 of their non-transgenic male siblings were placed in a 44 oz cup to compete for 10 wild type virgin females. The progeny of these females was screened for the Guy1 transgene and sexed at the L3 larval stage. Biological triplicates were performed for both nGuy1 lines. It was experimentally determined that transgenic females do not survive to the L3 stage (Figure 3C). Thus, the expected fractions for transgenic males, non-transgenic females, and non-transgenic males were 1/7, 3/7, and 3/7, respectively, assuming equal reproductive capability of the nGuy1 males and their siblings (see Figure 4—source data 1 for genotype explanation). In all three experiments and for both lines, there are more transgenic nGuy1 offspring than expected under the assumption of equal reproductive ability (Figure 4 and Figure 4—source data 1). The results are statistically significant for both nGuy1 transgenic lines according to one-sample proportion tests (Z=5.0 and 8.1, respectively; p<0.001 for both lines, Figure 4—source data 1). The significantly larger transgenic male population in comparison to the expected value suggests that the transgenic nGuy1 males were more competitive in reproductive output than their non-transgenic male siblings in the laboratory under our assay conditions.
-
Figure 4—source data 1
- https://doi.org/10.7554/eLife.19281.010
Guy1 expression does not require other factors from the Y chromosome
We have previously shown that Guy1 is the earliest transcribed of all known Y genes in An. stephensi, at the very onset of maternal-to-zygotic transition (Criscione et al., 2013). Here, we have shown that the native Guy1 promoter is active in the early embryos of both nGuy1 and Guy1m lines (Figure 2A and B). Furthermore, the Guy1 promoter is active in female embryos, according to direct evidence by RT-PCR (Figure 2A) and according to the fact that nGuy1 transgene affects females during the embryonic stage. These results from transgenic lines clearly indicate that the early embryonic gene expression controlled by the native Guy1 promoter does not rely on any other Y chromosome factors because Y chromosome is not present in the female embryos.
Discussion
Is Guy1 the M factor in An. stephensi?
The M factor is a primary signal from the male-determining chromosome or locus that triggers male development. We have previously shown that Guy1 is the earliest expressed Y chromosome gene and it is transcribed at the onset of maternal-to-zygotic transition, prior to sex-determination (Criscione et al., 2013). We have now shown in transgenic lines that the native Guy1 promoter is able to direct Guy1 transcription as well as GUY1 function when placed in the autosome of genetic females which lack the Y chromosome. Thus, Guy1 is a primary signal, not a secondary signal, from the Y chromosome. We have also provided evidence that the small GUY1 protein is the functional molecule by analyzing various Guy1 mutants or constructs in transgenic lines. When ectopically expressed in females, the small GUY1 protein confers 100% female lethality during embryonic and early larvae stages. As discussed in detail below, manipulations of master switches of sex-determination also cause sex-specific lethality in fruit flies and nematodes (Thomas et al., 2012; Schutt and Nothiger, 2000; Penalva and Sánchez, 2003). Taken together, we suggest that Guy1 is a strong candidate for the M factor in An. stephensi. Unlike the newly discovered M factor Nix in Ae. aegypti (Hall et al., 2015), ectopic expression of Guy1 did not produce masculinized XX females. However, a recently reported M factor in An. gambiae, gYG2/YOB, also confers female-specific lethality instead of sex conversion in a transient embryonic assay using in vitro synthesized YOB mRNA (Krzywinska et al., 2016). The cause of female lethality in the transgenic An. stephensi is unknown. A few scenarios are possible, one being related to dosage compensation, which is a mechanism known to occur in Anopheles mosquitoes ([Hahn and Lanzaro, 2005; Mank et al., 2011; Jiang et al., 2015] Rose et al., 2016), including An. stephensi (Jiang et al., 2015), to ensure equal levels of X-linked gene products in females (XX) and males (XY). It is intriguing that three known master switches of sex-determination, Sex-lethal, Fem/Masc, and xo-lethal 1, also regulate dosage compensation in D. melanogaster, Bombyx mori, and C. elegans, respectively ([Thomas et al., 2012; Schutt and Nothiger, 2000; Penalva and Sánchez, 2003; Kiuchi et al., 2014]). Loss of function Sex-lethal alleles cause female embryonic lethality in D. melanogaster due to mis-regulation of dosage compensation (Cline, 1978). Similarly, knockdown of Masc also casues female-specific letahlity in B. mori, most likely due to mis-regulation of dosage compensation (Kiuchi et al., 2014). If Guy1 is also involved in the regulation of dosage compensation in An. stephensi, ectopic expression of Guy1 in XX individuals may result in higher than normal levels of expression from X-linked genes, which could be lethal. Indeed, the sex-conversion phenotypes that resulted from ectopic expression of Nix were possible, presumably because Ae. aegypti does not require dosage compensation as it contains homomorphic sex-determining chromosomes (Hall et al., 2015).
There is no significant similarity between GUY1 and gYG2/YOB in their primary amino acid sequences. Thus, it will be difficult to determine whether Guy1 and YG2/YOB have a common evolutionary origin, especially as Y chromosome genes tend to evolve rapidly and similarities between very small proteins may not be easy to detect. However, both GUY1 and gYG2/YOB proteins are 56 amino acid long and have helical secondary structures (Criscione et al., 2013; Krzywinska et al., 2016). In addition, four out of the first five amino acid residues are identical between GUY1 and gYG2/YOB proteins. Thus, we cannot yet rule out the possibility that GUY1 and gYG2/YOB may be evolutionarily related. Regardless, it is unlikely that Guy1 and gYG2/YOB are complete functional orthologs because Guy1 is only expressed in the early embryos in An. stephensi (tapering off at 8–12 hr after egg laying, Criscione et al., 2013) while gYG2/YOB is expressed in the early embryos as well as in later developmental stages in An. gambiae (Hall et al., 2013; Krzywinska et al., 2016). Our hypothesis is that Guy1 is the initial or primary signal which triggers a cascade of events downstream. This is analogous to the early Sex-lethal gene product (SXLe) in D. melanogaster (reviewed in [Herpin and Schartl, 2015]), which is only produced during the early embryonic stage. This transient primary signal, SXLe, is sufficient to trigger the female-specific cascade of events that are then maintained by downstream factors such as the late SXL protein throughout development. The transient expression of Guy1 suggests that it may function as a trigger or initiating signal, but not as a gene that maintains sexual identity. If additional Y genes are indeed required for either initiating or maintaining sex determination in An. stephensi, ectopic expression of Guy1 alone may not be sufficient to change dsx splicing in female cells/embryos due to the lack of Y chromosome. The transient and early embryonic expression of Guy1 also made it difficult to knockdown Guy1 simply because there is not enough time for RNAi to work in the early embryos. However, further characterization of other Y genes in An. stephensi may enable the experimental demonstration of potential Guy1 targets, which could lead to the elucidation of the Guy1-dependent developmental pathway in the early embryos.
Complete penetrance, stable inheritance, early-stage lethality, and reproductive competitiveness indicate the potential for powerful applications
Our results demonstrated, for the first time in mosquitoes, that a Y chromosome gene, namely Guy1, confers 100% female lethality when ectopically expressed from an autosome in XX individuals and this effect can be stably inherited for many generations. Recent work showed that ectopic expression of an M factor Nix in Ae. aegypti initiated male development in genetic females (Hall et al., 2015) and embryonic injection of in vitro synthesized gYG2/YOB mRMA conferred female-specific lethality in An. gambiae (Krzywinska et al., 2016). However, the stability and penetrance of the phenotypes conferred by the Nix or gYG2/YOB transgenes remain to be determined as Nix or gYG2/YOB transgenic lines have yet to be reported (Hall et al., 2015; Krzywinska et al., 2016). Here, we have proved in principle that sustained sex ratio manipulation can be achieved using a Y chromosome gene with high penetrance. Furthermore, males that carry the Guy1 transgene are more competitive in overall reproductive output than their non-transgenic male siblings under laboratory conditions. Future studies based on analysis of progeny of individual females mated with transgenic and wildtype males will give insight regarding the mating competitiveness of the transgenic individuals. Competitive assays performed in semi-field or field conditions are needed to determine whether ectopic expression of Guy1 truly makes the males reproductively more competitive than wild type mosquitoes. Nonetheless, data presented in this study suggest that the Guy1 transgene shows no obvious detrimental effects in males and may be developed as a new method to generate male-only mosquitoes for release.
As mentioned earlier, transgenic lines that produce only male progeny will improve current sex-separation methods and provide new ways to reduce mosquito population and disease transmission. The Guy1 transgenic lines offer several attractive features in this regard. With regard to sex separation, 100% female lethality is ideal for both effectiveness and ethical considerations of not accidentally releasing females. In addition, released females can compete with wild-type females to mate with the released males simply due to their presence and even through assortative mating. Thus, the complete penetrance of the male-only phenotype, as seen in every Guy1 transgenic line over many generations, with the exception of the negative controls, is a highly attractive feature when developing a novel genetic sex-separation approach based on Guy1. The current mass production of male mosquitoes relies on physical means of sex separation, which is labor-intensive, expensive, and not 100% accurate ([Alphey, 2014; Gilles et al., 2014]). Transgenic lines that express fluorescent markers in a sex-specific pattern have been developed to allow machine-based sorting of the sexes (e.g., [Catteruccia et al., 2005; Marois et al., 2012]). However, such an approach is expensive with a relatively low throughput (Gilles et al., 2014). Another positive feature of the Guy1 lines is the embryonic or early larvae lethality, which negates the need to rear female larvae altogether. The Guy1 transgenic lines also offer a few important advantages to strategies for reducing mosquito populations and disease transmission. The observed 100% female lethality will result in bias towards the non-biting males in multiple generations, which is theoretically much more efficient than classic sterile insect techniques in achieving population reduction and disease control ([Thomas et al., 2000; Schliekelman et al., 2005]). An exciting report recently showed that an artificial sex ratio distortion system based on the shredding of the An. gambiae X chromosome produced >95% male offspring (Galizi et al., 2014). The 100% female lethality described here was accomplished by simply expressing the endogenous Guy1 gene from the autosome. Thus, the Guy1-based genetic strategy involves minimal genetic manipulation.
The existing Guy1 transgenic lines are heterozygous. Because no female transgenic individuals passed the first instar, homozygous individuals cannot be produced by mating transgenic males with transgenic females. Conditional control of transgenic Guy1 expression will enable the production of transgenic females required for generating homozygous transgenic individuals ([Phuc et al., 2007; Marinotti et al., 2013; Fu et al., 2007]), which is necessary for field applications. Alternatively, the Guy1 transgene may be linked to recently developed CRISPR/cas9-based gene drives (Gantz et al., 2015; Hammond et al., 2016) for rapid spread of this female-lethal gene over multiple generations. This may represent an effective yet self-limiting strategy to control mosquito-borne infectious diseases because the spread of Guy1 could lead to severe reduction or local extinction of An. stephensi populations due to the lack of females (Adelman and Tu, 2016). Research on Guy1 has shown great promise for genetic control of mosquito-borne infectious diseases and revealed the complex and sex-specific effect of a Y gene during mosquito embryonic development. The unexplored mosquito Y chromosome may in fact turn out to be a gold mine for intriguing stories about sexual dimorphism and promising leads for new ways to control mosquito-borne infectious diseases.
Materials and methods
Rearing of mosquitoes
Request a detailed protocolWild type Indian strain ('type' form) of An. stephensi and transgenic An. stephensi were reared in incubators at 27°C and 60% relative humidity on a 16 hr light/8 hr dark photoperiod. Larvae were fed Sera Micron Fry Food with brewer's yeast, and Purina Game Fish Chow. Adult mosquitoes were fed on a 10% sucrose soaked cotton pad (Criscione et al., 2013).
piggyBac donor plasmids
Request a detailed protocolAll donor plasmids (Figure 1A–D) were constructed by inserting the gene of interest into a piggyBac donor plasmid backbone that contained the piggyBac arms and the DsRed transformation marker cassette (Horn et al., 2000). The nGuy1 plasmid (Figure 1A) contained the native Guy1 gene, which included the full length Guy1 cDNA sequence (5’ UTR, CDS and 3’ UTR) and the previously tested Guy1 native promoter (Criscione et al., 2013). The native Guy1 gene was PCR amplified using genomic DNA from adult male An. stephensi as a template and primers are shown in Table 3. A second round of PCR was performed to adapt AscI and PacI sites to clone into the above mentioned donor plasmid backbone. The nGuy1 plasmid and all other plasmids constructed in this study were verified by Sanger sequencing at the Virginia Bioinformatics Institute (VBI) on the Virginia Tech campus. The Guy1m plasmid (Figure 1B) is identical to nGuy1 except for a point mutation that changed the start codon ATG to AAG. The point mutation was introduced by synthesizing and replacing the fragment between the NheI and BglII sites in nGuy1 (Epoch Life Science, Inc., Missouri City, TX). bGuy1C (Figure 1C) contained the 168 bp Guy1 open reading frame (ORF) plus a C-terminal Strep II tag (22) and the 5’UTR was provided from an An. stephensi early zygotic gene bZip1 (Genbank JQ266223) and the 3’ UTR from SV40. Cloning of bGuy1C was done by gene synthesis (Epoch Life Science, Inc., Missouri City, TX) and the sequence of the synthesized fragment is provided in the supplemental file. bGuy1N (Figure 1D) is similar to bGuy1C except that the Strep II tag is at the N-terminus and the 119 bp Guy1 3’ UTR was used instead of the SV40 3’ UTR. Cloning of bGuy1N was also done by gene synthesis (Epoch Life Science, Inc., Missouri City, TX) and the sequence of the synthesized fragment is provided in the supplemental file.
Embryonic injection
Request a detailed protocolThe preblastoderm embryo injection was performed at the University of Maryland, College Park, Institute for Bioscience and Biotechnology Research’s Insect Transformation Facility (http://www.ibbr.umd.edu/facilities/itf). For the nGuy1 and Guy1m experiments, an injection solution was used that contains a 150 ng/μl donor plasmid, a 300 ng/μl piggyBac transposase (phsp-Pbac) helper plasmid (Horn et al., 2000), and a 200 ng/μl actin5C-EGFP plasmid. Crossing of G0 and screening were performed at Virginia Tech as described below. The bGuy1C and bGuy1N lines were generated at the University of Maryland Facility using a similar injection method as the one described above. No actin5c-EGFP plasmid was included. Instead, a plasmid mixture was included for monitoring the quality of injections consisting of a minimal Minos vector (pMin QC) and a source of Minos transposase (pHSS6hsILMi20).
Screening for transgenic lines
Request a detailed protocolInjected embryos for nGuy1 and Guy1m constructs were obtained from the University of Maryland Insect Transformation Facility and reared to adulthood. G0 adult males were individually mated with five wild type females while G0 females were pooled and mated with wild type males at a 1 male to 5 female ratio. Mosquitoes were blood-fed on female Hsd:ICR (CD-1) mice (Harlan Laboratories, http://www.harlan.com). Egg collection occurred approximately 3 days post blood-feeding. Larvae were screened for DsRed expression during the L3 stage. G1 males and females were segregated after emergence and mated with wild type at a 1 male to 5 female ratio. The nGuy1 and bGuy1 lines produced no females, therefore, subsequent generations were maintained with the addition of up to 50 virgin wild type females. Females were produced in the Guy1m line and the line was allowed to inbreed.
Inverse PCR and ddPCR
Request a detailed protocolInverse PCR was used to identify insertion sites of the nGuy1 and Guy1m transgenes. Genomic DNA was extracted with the gDNA Isolation Kit (Zymo Research) from 10 adult males in each transgenic line: nGuy1-1, nGuy1-2, and Guy1m. Digestion of 1 μg of gDNA was performed overnight at 37°C with 80 units of restriction enzyme and 1x digestion buffer. Digestions were performed with HaeIII, PacI, and MspI and inactivated at 85°C for 5 min. The digested DNA was then allowed to self-ligate overnight at 4°C in a 200 μL ligation reaction consisting of 20 μL 10X ligation buffer, 40 μL digestion reaction, 10 μL DNA ligase, and 130 μL H2O. The ligated product was then purified with the illustra GFX Gel Band Purification Kit (GE Healthcare). Purified DNA was used as the template in PCR amplification using the piggyBac right hand primer sets (Table 3) and the rTaq polymerase (Takara). Cycling conditions for the first round of PCR and nested PCR were as follows: 95°C for 3 min; 30 cycles of 95°C for 30 s, 56°C for 30 s, 72°C for 3 min; and a final extension time of 5 min. PCR products were run on a 1% agarose gel, excised and purified with the illustra GFX Gel Band Purification Kit (GE Healthcare). The purified PCR product was cloned into the pGEM-T easy vector. JM109 cells were transformed with each reaction mix and grown on LB+Ampicilin plates overnight at 37°C. Individual colonies were cultured in 3 mL LB overnight and PCR screened for the correct insertion. Plasmids were sequenced at VBI. The transgene copy number was determined by digital droplet PCR using DsRed primers and primers for an autosomal reference gene (Table 3) as described in Hindson et al. (Hindson et al., 2011).
Transgene expression
Request a detailed protocolAnalysis of the Guy1 transgene in the bGuy1C and bGuy1N lines were straightforward and transgene-specific primers can be used for RT-PCR (Figure 2 and Table 3). For the Guy1m line, we were able to take advantage of the ATG to AAG mutation, which generated a MseI site that was not present in the endogenous Guy1 transcripts. Thus, RNA was isolated from 5–6 hr embryos collected from Guy1m females and used for cDNA synthesis. Specific RT-PCR primers were designed to encompass a 130 bp region, which lacks the MseI site in the endogenous Guy1 transcript. RT-PCR products were then digested with MseI to show transgene expression as indicated by the appearance of 90 and 40 bp fragments (Figure 2). The uncut band reflects RT-PCR products from the endogenous Guy1 transcripts.
For nGuy1 lines, there is no difference between the transgene and endogenous Guy1 transcripts. In order to confirm transgene expression, we have to genotype individual embryos to show that the Guy1 transgene is transcribed in transgenic females, which lack endogenous Guy1. Individual 5–6 hr old embryos were homogenized in 5 uL Lysis Buffer (0.05M DTT and 10U RNase OUT from Invitrogen). The lysate was flash frozen and stored at −80°C until gDNA preparation or RNA extraction was required. The lysate was split in half, one for genotyping and one for RT-PCR (19). For gDNA isolation 2.5 uL of the lysate was treated with 0.3 mAU of proteinase K for 30 min at 28°C, and then inactivated at 95°C for 2 min. The reaction was then diluted with 6.5 uL of ddH2O. The gDNA of each embryo was then used as the template to amplify RPS4, sYG2, and the transgene in PCR reactions for genotyping purposes (see Table 3 for primers). Transgene was amplified by primers encompassing DsRed and Guy1. sYG2 is a Y chromosome gene and RPS4 is the ribosomal protein subunit 4 positive control. sYG2 and RPS4 positive and transgene negative individuals were considered wild-type male embryos. sYG2, RPS4, and transgene positive individuals were considered transgenic males. Transgene and RPS4 positive and sYG2 negative embryos were considered transgenic females. Finally, RPS4 positive and sYG2 and transgene negative individuals were considered wild-type females. For RNA isolation 2.5 uL of the lysate was treated with 130U of DNase I (Invitrogen, Carlsbad, CA) for 1 hr at 25°C. The reaction was stopped with the addition of 1 μL of 25 mM EDTA and incubation at 65°C for 10 min. The resulting 4.5 μL reaction was carried over to cDNA synthesis using the SuperScript III reverse transcriptase and random hexamers. The cycling conditions for all reactions were as follows: 95°C for 5 min; 40 cycles at 95°C for 30 s, 60°C for 30 s, and 72°C for 3 min; and final extension at 72°C for 5 min. PCR products were run on a 1% agarose gel (Figure 2).
Reproductive competitiveness of transgenic males
Request a detailed protocolMating competence of transgenic males was measured through competition against non-transgenic sibling males for mates with wild type females. F1 transgenic males were mated with wild type virgin females. The resulting F2 progeny was checked for expression of DsRed and for the presence of testes. Males that were DsRed positive and DsRed negative (siblings) were reared separately in pans with equal larval density. Two days after emerging, twenty transgenic males and twenty non-transgenic males were placed in a 44 oz Coke cup (44TDCB) together. Ten wild type virgin females (approximately three days post pupal emergence) were introduced and allowed to mate for twenty-four hours with the mixed males. The females were then blood fed for a minimum of thirty minutes and inspected for feeding. Seventy-two hrs post blood feeding, eggs were collected from these females for 24 hrs. The subsequent F3 progeny were screened for DsRed and sexed at the L3 larval stage. Biological triplicates were performed for these sets of experiments. The expected results for transgenic males, non-transgenic females, and non-transgenic males were 1/7, 3/7, and 3/7, respectively (see note of Figure 4—source data 1 for detailed explanations). It has already been experimentally determined that transgenic females do not survive to the L3 stage and are, thus, not calculated into the expected progeny ratios.
References
-
Control of mosquito-borne infectious diseases: Sex and gene driveTrends in Parasitology 32:219–229.https://doi.org/10.1016/j.pt.2015.12.003
-
Genetic control of mosquitoesAnnual Review of Entomology 59:205–224.https://doi.org/10.1146/annurev-ento-011613-162002
-
Sex determination: why so many ways of doing it?PLoS Biology 12:e1001899.https://doi.org/10.1371/journal.pbio.1001899
-
Triploids and male determination in the mosquito, Anopheles culicifaciesThe Journal of Heredity 70:345–346.
-
The first releases of transgenic mosquitoes: an argument for the sterile insect techniqueTrends in Parasitology 19:349–355.https://doi.org/10.1016/S1471-4922(03)00144-2
-
Origin and evolution of Y chromosomes: Drosophila talesTrends in Genetics 25:270–277.https://doi.org/10.1016/j.tig.2009.04.002
-
BookSex determination in mosquitoesIn: Raikhel A, editors. Progress in Mosquito Research, Advances in Insect Physiology (51). London: Elsevier. pp. 37–66.https://doi.org/10.1016/bs.aiip.2016.05.005
-
Sex determination in insects: variations on a common themeSexual Development 8:20–28.https://doi.org/10.1159/000356458
-
An Anopheles transgenic sexing strain for vector controlNature Biotechnology 23:1414–1417.https://doi.org/10.1038/nbt1152
-
Two closely linked mutations in Drosophila melanogaster that are lethal to opposite sexes and interact with daughterlessGenetics 90:683–698.
-
Female-specific insect lethality engineered using alternative splicingNature Biotechnology 25:353–357.https://doi.org/10.1038/nbt1283
-
High-throughput droplet digital PCR system for absolute quantitation of DNA copy numberAnalytical Chemistry 83:8604–8610.https://doi.org/10.1021/ac202028g
-
Highly sensitive, fluorescent transformation marker for Drosophila transgenesisDevelopment Genes and Evolution 210:623–629.https://doi.org/10.1007/s004270000111
-
Complete dosage compensation in Anopheles stephensi and the evolution of sex-biased genes in mosquitoesGenome Biology and Evolution 7:1914–1924.https://doi.org/10.1093/gbe/evv115
-
Comparison of affinity tags for protein purificationProtein Expression and Purification 41:98–105.https://doi.org/10.1016/j.pep.2005.01.019
-
Sex separation strategies: past experience and new approachesMalaria Journal 8 (Suppl 2):S5.https://doi.org/10.1186/1475-2875-8-S2-S5
-
RNA binding protein sex-lethal (Sxl) and control of Drosophila sex determination and dosage compensationMicrobiology and Molecular Biology Reviews 67:343–359.https://doi.org/10.1128/MMBR.67.3.343-359.2003
-
Dosage Compensation in the African Malaria Mosquito Anopheles gambiaeGenome Biology and Evolution 8:411–425.https://doi.org/10.1093/gbe/evw004
-
Identification of sex-specific transcripts of the Anopheles gambiae doublesex geneJournal of Experimental Biology 208:3701–3709.https://doi.org/10.1242/jeb.01819
-
Pest control by genetic manipulation of sex ratioJournal of Economic Entomology 98:18–34.https://doi.org/10.1093/jee/98.1.18
-
Structure, function and evolution of sex-determining systems in Dipteran insectsDevelopment 127:667–677.
-
Sex-determining mechanisms in insectsThe International Journal of Developmental Biology 52:837–856.https://doi.org/10.1387/ijdb.072396ls
Article and author information
Author details
Funding
National Institute of Allergy and Infectious Diseases (AI105575)
- Zhijian Tu
National Institute of Allergy and Infectious Diseases (AI121284)
- Zhijian Tu
Virginia Experimental Station (HATCH project 135998)
- Zhijian Tu
National Institute of Allergy and Infectious Diseases (AI77680)
- Zhijian Tu
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
This work was supported by NIH grants AI105575, AI77680, and AI121284 to ZT and by the Virginia Experimental Station. We thank Jim Biedler, Janet Webster, Brantley Hall for critical review of the manuscript; Wanqi Hu for RT-PCR; Jim Biedler for cloning of some of the Guy1 constructs; Brantley Hall and Xiaofang Jiang for revising the figures; Randy Saunders for mosquito care. We thank Robert Harrell of the Insect Transgenic Facility at the University of Maryland for embryonic injections and for generating the bGuy1C and bGuyN lines. The X-linked CFP line was provided by Anthony James of the University of California, Irvine.
Ethics
Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocol (#16-067) of Virginia Tech.
Copyright
© 2016, Criscione et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,249
- views
-
- 441
- downloads
-
- 58
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
- Microbiology and Infectious Disease
Candida glabrata can thrive inside macrophages and tolerate high levels of azole antifungals. These innate abilities render infections by this human pathogen a clinical challenge. How C. glabrata reacts inside macrophages and what is the molecular basis of its drug tolerance are not well understood. Here, we mapped genome-wide RNA polymerase II (RNAPII) occupancy in C. glabrata to delineate its transcriptional responses during macrophage infection in high temporal resolution. RNAPII profiles revealed dynamic C. glabrata responses to macrophages with genes of specialized pathways activated chronologically at different times of infection. We identified an uncharacterized transcription factor (CgXbp1) important for the chronological macrophage response, survival in macrophages, and virulence. Genome-wide mapping of CgXbp1 direct targets further revealed its multi-faceted functions, regulating not only virulence-related genes but also genes associated with drug resistance. Finally, we showed that CgXbp1 indeed also affects fluconazole resistance. Overall, this work presents a powerful approach for examining host-pathogen interaction and uncovers a novel transcription factor important for C. glabrata’s survival in macrophages and drug tolerance.
-
- Chromosomes and Gene Expression
- Neuroscience
Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.